{"id":4140,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2012-12-10","marketCap":2474.11,"name":"Neogenomics Inc","phone":"12397680600.0","outstanding":127.55,"symbol":"NEO","website":"https://neogenomics.com/","industry":"Health Care"},"price":17.6575,"year":2024,"month":8,"day":1,"weekday":"Thursday","title":"Corporate Governance Practices of Neogenomics Inc","date":"2024-08-01","url":"/posts/2024/08/01/NEO","content":[{"section":"Board Composition","text":"Neogenomics Inc has a diverse and experienced board of directors. The board consists of eight members, including the CEO and founder, an independent chairman, and six independent directors. The independent directors bring a wealth of expertise and experience from various industries, including healthcare, finance, and technology. This diverse composition ensures that the board has a wide range of perspectives and skill sets to effectively oversee the company's operations."},{"section":"Executive Compensation","text":"Neogenomics Inc has a transparent and performance-based executive compensation structure. The company utilizes a mix of salary, annual cash incentives, and long-term equity incentives to align the interests of executives with shareholders. The executives' compensation is tied to key financial metrics, such as revenue growth, profitability, and return on investment. This performance-based approach encourages the executives to focus on the company's long-term success and shareholder value creation."},{"section":"Board Independence","text":"Neogenomics Inc prioritizes board independence to ensure effective oversight and decision-making. The majority of the board members are independent directors who do not have any material relationships with the company. This independence helps prevent conflicts of interest and promotes a culture of accountability and transparency within the company."},{"section":"Committee Structure","text":"Neogenomics Inc has established several committees to enhance corporate governance and oversight. These committees include the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, and Science and Technology Committee. Each committee is composed of independent directors who bring specialized expertise in their respective areas. This committee structure allows for in-depth analysis and focused decision-making on important matters, such as financial reporting, executive compensation, and board nominations."},{"section":"Shareholder Rights","text":"Neogenomics Inc recognizes the importance of protecting shareholder rights. The company has implemented various measures to ensure transparency and fair treatment of shareholders. These measures include proxy access, which enables shareholders to nominate directors, and regular communication through quarterly earnings releases, annual reports, and investor presentations. Neogenomics Inc also encourages shareholder engagement and actively seeks feedback to improve its corporate governance practices."},{"section":"Ethics and Compliance","text":"Neogenomics Inc emphasizes ethics and compliance in its corporate governance practices. The company has established a Code of Conduct and business ethics policy that outlines the standards of behavior expected from employees, directors, and officers. Neogenomics Inc also maintains a robust compliance program to identify and mitigate risks related to legal, regulatory, and ethical issues. This commitment to ethics and compliance helps foster a culture of integrity and responsible business practices."},{"section":"Executive Succession Planning","text":"Neogenomics Inc recognizes the importance of executive succession planning for long-term sustainability. The company has a formal succession planning process in place to identify and develop future leaders within the organization. This process includes assessing internal candidates, providing leadership development opportunities, and establishing clear criteria and timelines for succession. By actively preparing for future leadership transitions, Neogenomics Inc can ensure continuity and stability in its operations."},{"section":"Conclusion","text":"Neogenomics Inc demonstrates strong corporate governance practices through its diverse board composition, performance-based executive compensation, emphasis on board independence, committee structure, protection of shareholder rights, ethics and compliance focus, and executive succession planning. These practices promote transparency, accountability, and responsible decision-making, ultimately contributing to the company's long-term success and shareholder value."}],"tags":["CrossOver21","Long","Health Care"],"news":[{"category":"company","date":1722344280,"headline":"Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session","id":129007134,"image":"","symbol":"NEO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577942113"},{"category":"company","date":1722337800,"headline":"What You Missed On Wall Street This Morning","id":129004759,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577807074"},{"category":"company","date":1722334740,"headline":"What's Driving NeoGenomics Inc's Surprising 23% Stock Rally?","id":129004465,"image":"","symbol":"NEO","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577746384"},{"category":"company","date":1722332880,"headline":"PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black \u0026 Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday","id":129004143,"image":"","symbol":"NEO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577708882"},{"category":"company","date":1722326280,"headline":"Bank of America Securities Sticks to Its Hold Rating for NeoGenomics (NEO)","id":129007054,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577580440"},{"category":"company","date":1722321480,"headline":"Benchmark Co. Sticks to Their Buy Rating for NeoGenomics (NEO)","id":129007055,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577501310"},{"category":"company","date":1722318600,"headline":"Piper Sandler Sticks to Its Buy Rating for NeoGenomics (NEO)","id":129007056,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577461439"},{"category":"company","date":1722316740,"headline":"Buy Rating Reiterated for NeoGenomics Amidst Strong Financial Performance and Market Positioning","id":129007057,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577439800"},{"category":"company","date":1722311100,"headline":"What You Missed On Wall Street On Tuesday","id":129012689,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3578171838"},{"category":"company","date":1722308460,"headline":"NeoGenomics Inc (NEO) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...","id":129007058,"image":"","symbol":"NEO","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577350724"},{"category":"company","date":1722290408,"headline":"Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 Earnings","id":128994468,"image":"https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462","symbol":"NEO","publisher":"Yahoo","summary":"Although the revenue and EPS for NeoGenomics (NEO) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.","url":"https://finance.yahoo.com/news/heres-key-metrics-tell-us-220008718.html"},{"category":"company","date":1722285224,"headline":"NeoGenomics: Q2 Earnings Snapshot","id":128990141,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"NEO","publisher":"Yahoo","summary":"NEO) on Monday reported a loss of $18.6 million in its second quarter. On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 15 cents. Earnings, adjusted for stock option expense and amortization costs, came to 3 cents per share.","url":"https://finance.yahoo.com/news/neogenomics-q2-earnings-snapshot-203344350.html"},{"category":"company","date":1722284043,"headline":"NeoGenomics, Inc. (NEO) Q2 2024 Earnings Call Transcript","id":128994078,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"NEO","publisher":"SeekingAlpha","summary":"NeoGenomics, Inc. (NASDAQ:NASDAQ:NEO) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ETCompany ParticipantsKendra Sweeney - VP of IRChris Smith -...","url":"https://seekingalpha.com/article/4707802-neogenomics-inc-neo-q2-2024-earnings-call-transcript"},{"category":"company","date":1722283500,"headline":"NeoGenomics Reports Second Quarter 2024 Results","id":128990142,"image":"https://s.yimg.com/ny/api/res/1.2/7fHouCe.u1VHVyP_BjfuDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00OTQ-/https://media.zenfs.com/en/business-wire.com/3f12b8c87f3694c61ab43cf00aff61d8","symbol":"NEO","publisher":"Yahoo","summary":"FORT MYERS, Fla., July 29, 2024--NeoGenomics announced its second-quarter results for the period ended June 30, 2024.","url":"https://finance.yahoo.com/news/neogenomics-reports-second-quarter-2024-200500230.html"},{"category":"company","date":1722274267,"headline":"NeoGenomics, Inc. 2024 Q2 - Results - Earnings Call Presentation","id":128990807,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"NEO","publisher":"SeekingAlpha","summary":"The following slide deck was published by NeoGenomics, Inc.","url":"https://seekingalpha.com/article/4707784-neogenomics-inc-2024-q2-results-earnings-call-presentation"},{"category":"company","date":1722252960,"headline":"Buy Rating Affirmed for NeoGenomics Amid Solid Sales Growth and Expanding Margins","id":129007059,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577229748"},{"category":"company","date":1722240540,"headline":"Strong Buy Recommendation for NeoGenomics Amidst Operational Efficiency and Growth Potential","id":129007060,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577024489"},{"category":"company","date":1722240000,"headline":"NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024","id":129007061,"image":"","symbol":"NEO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577014070"},{"category":"company","date":1722238080,"headline":"NeoGenomics reports Q2 EPS (15c), consensus 0c","id":129007065,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3576988357"},{"category":"company","date":1722238080,"headline":"NeoGenomics raises FY24 revenue view to $655M-$667M from $650M-$660M","id":129007063,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3576988362"},{"category":"company","date":1722238080,"headline":"NeoGenomics options imply 9.5% move in share price post-earnings","id":129007062,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3576988321"},{"category":"company","date":1722224220,"headline":"NeoGenomics Inc (NEO) Q2 2024 Earnings: EPS and Revenue Beat Estimates with $165M Revenue and ...","id":128991293,"image":"","symbol":"NEO","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3576759973"},{"category":"company","date":1722223020,"headline":"NeoGenomics Non-GAAP EPS of $0.03 beats by $0.03, revenue of $165M beats by $3M","id":128991294,"image":"","symbol":"NEO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3576740844"},{"category":"company","date":1722141480,"headline":"NeoGenomics Q2 2024 Earnings Preview","id":128991296,"image":"","symbol":"NEO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3575625807"},{"category":"company","date":1722141480,"headline":"Notable earnings after Monday's close","id":128984206,"image":"","symbol":"NEO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3575625798"},{"category":"company","date":1721652063,"headline":"NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago","id":128834762,"image":"https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3","symbol":"NEO","publisher":"Yahoo","summary":"NeoGenomics, Inc. ( NASDAQ:NEO ) shareholders should be happy to see the share price up 10% in the last month. But over...","url":"https://finance.yahoo.com/news/neogenomics-nasdaq-neo-shareholders-endured-124103008.html"},{"category":"company","date":1721630880,"headline":"Neo Performance Welcomes New Board Expertise","id":128844536,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3566630671"},{"category":"company","date":1721477368,"headline":"Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?","id":128812398,"image":"https://s.yimg.com/ny/api/res/1.2/He382QsR3d74LByFHMmOuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/b7842bfdf308215f98e7f4a3bfa22607","symbol":"NEO","publisher":"Yahoo","summary":"We recently compiled a list of the 20 Most Profitable Stocks of the Last 20 Years. In this article, we are going to take a look at where NeoGenomics, Inc. (NASDAQ:NEO) stands against the other profitable stocks. The stock market has a long history of generating wealth for investors. While past performance doesn’t guarantee future […]","url":"https://finance.yahoo.com/news/neogenomics-inc-neo-most-profitable-120928120.html"}]}